Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system

BACKGROUND: mRNA COVID-19 vaccines manufactured by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) have been shown to be efficacious but have not been compared in head-to-head clinical trials. METHODS: We designed this observational study to emulate a target trial of COVID-19 vaccination by BNT16...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannou, George N., Locke, Emily R., Green, Pamela K., Berry, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896984/
https://www.ncbi.nlm.nih.gov/pubmed/35261970
http://dx.doi.org/10.1016/j.eclinm.2022.101326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896984/
https://www.ncbi.nlm.nih.gov/pubmed/35261970
http://dx.doi.org/10.1016/j.eclinm.2022.101326

Ejemplares similares